Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash	$ 1,587,086	$ 1,271,824
Prepaid expenses and other current assets	1,024,850	426,497
Deferred transaction costs	199,724	1,005,109
Promissory notes issued	495,397
Total current assets	3,307,057	2,703,430
Computer and equipment, net	14,830	1,968
Pre-acquisition capital project costs	1,937,487	100,000
Investment in equity securities	67,562	218,556
Other long-term assets	50,000
Total assets	5,376,936	3,023,954
Current liabilities
Accounts payable	6,494,165	1,256,792
Accrued liabilities and other current liabilities	4,129,258	208,107
Current portion of early exercised shares option liability	4,408	2,990
Short-term loan	383,797	72,967
Total current liabilities	11,011,628	1,540,856
SAFE notes		5,212,200
Warrant liability	4,693,859
Earnout liability	2,972,800
Early exercised shares option liability	3,259	5,660
Total liabilities	18,681,546	6,758,716
Commitments and contingencies (Note 2)
Stockholders’ equity (deficit)
Preferred stock, $0.0001 par value, 100,000,000 and Nil shares authorized, Nil shares issued and outstanding as at September 30, 2024 and December 31, 2023
Common stock, $0.0001 par value, 700,000,000 and 69,033,000 shares authorized, 47,872,445 and 41,499,772 shares issued and outstanding as at September 30, 2024 and December 31, 2023, respectively	4,573	4,023
Additional paid-in capital	29,741,789	54,800
Accumulated deficit	(43,050,972)	(3,793,585)
Total stockholders’ deficit	(13,304,610)	(3,734,762)
Total liabilities and stockholders’ deficit	$ 5,376,936	$ 3,023,954